Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?

BACKGROUND/AIMS: Screening for latent tuberculosis infection is mandatory before starting anti-tumor necrosis factor therapy. New assays based on interferon-γ (IFN-γ) release have recently become available and may be more accurate. The aim of this study was to compare QuantiFERON-TB and tuberculin s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Gastroenterol
Autors principals: Cabriada, José Luis, Ruiz-Zorrilla, Rafael, Barrio, Jesús, Atienza, Ramón, Huerta, Alain, Rodríguez-Lago, Iago, Bernal, Antonio, Herrero, César
Format: Artigo
Idioma:Inglês
Publicat: Turkish Society of Gastroenterology 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6284653/
https://ncbi.nlm.nih.gov/pubmed/29755013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2018.17162
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars